These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38501491)

  • 1. Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations.
    Chang YP; Pan PC; Tu LH
    Protein Sci; 2024 Apr; 33(4):e4952. PubMed ID: 38501491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH
    J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments.
    Chuang YP; Chang YP; Tu LH
    Protein Sci; 2023 Aug; 32(8):e4711. PubMed ID: 37354016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.
    Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y
    J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity.
    Hsieh IC; Chen TW; Chuang YP; Lai YJ; Tu LH
    Biochimie; 2022 Jun; 197():121-129. PubMed ID: 35240220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin.
    Yan J; Wang Y; Fan X; Zou Y; Ding F; Huang F; Sun Y
    Soft Matter; 2024 Jan; 20(3):693-703. PubMed ID: 38164981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
    Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
    J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
    Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
    J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin.
    Huang F; Huang J; Yan J; Liu Y; Lian J; Sun Q; Ding F; Sun Y
    J Chem Inf Model; 2024 Jun; 64(11):4500-4510. PubMed ID: 38745385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation.
    Itoh-Watanabe H; Kamihira-Ishijima M; Javkhlantugs N; Inoue R; Itoh Y; Endo H; Tuzi S; Saitô H; Ueda K; Naito A
    Phys Chem Chem Phys; 2013 Jun; 15(23):8890-901. PubMed ID: 23552643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-Conjugated Carbon Dots Inhibit Human Calcitonin Fibrillation.
    Wu JA; Chen YC; Tu LH
    Nanomaterials (Basel); 2021 Aug; 11(9):. PubMed ID: 34578556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
    J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrocaffeic Acid-Decorated Iron Oxide Nanomaterials Effectively Inhibit Human Calcitonin Aggregation.
    Shen CL; Wu YH; Zhang TH; Tu LH
    ACS Omega; 2022 Sep; 7(35):31520-31528. PubMed ID: 36092590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity.
    Shang H; Zhou A; Jiang J; Liu Y; Xie J; Li S; Chen Y; Zhu X; Tan H; Li J
    Acta Biomater; 2018 Sep; 78():178-188. PubMed ID: 30076991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation.
    Lantz R; Busbee B; Wojcikiewicz EP; Du D
    Biopolymers; 2020 May; 111(5):e23343. PubMed ID: 31804717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y12 nitration of human calcitonin (hCT): A promising strategy to produce non-aggregation bioactive hCT.
    Ye H; Li H; Gao Z
    Nitric Oxide; 2020 Nov; 104-105():11-19. PubMed ID: 32827754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.
    Ye H; Zhou J; Li H; Gao Z
    J Inorg Biochem; 2019 Jul; 196():110686. PubMed ID: 31003065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias.
    Andreassen KV; Hjuler ST; Furness SG; Sexton PM; Christopoulos A; Nosjean O; Karsdal MA; Henriksen K
    PLoS One; 2014; 9(3):e92042. PubMed ID: 24643196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced potency of human calcitonin when fibrillation is avoided.
    Cudd A; Arvinte T; Das RE; Chinni C; MacIntyre I
    J Pharm Sci; 1995 Jun; 84(6):717-9. PubMed ID: 7562410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.